https://www.selleckchem.com/products/sn-011-gun35901.html ent, and future research on elder abuse are discussed. Structural visualization and analysis are fundamental to explore macromolecular functions. Here we present a novel integrative web-based virtual reality (VR) system - VRmol, to visualize and study molecular structures in an immersive virtual environment. Importantly, it is integrated with multiple online databases and able to couple structure studies with associated genomic variations and drug information in a visual interface by cloud-based drug docking. VRmol thus can serve as an integrative platform to aid structure-based translational research and drug design. VRmol is freely available (https//VRmol.net), with detailed manual and tutorial (https//VRmol.net/docs). The code of VRmol is available as open source under the MIT license at http//github.com/kuixu/VRmol. Supplementary data are available at Bioinformatics online. Supplementary data are available at Bioinformatics online. Advances in genomic technologies have facilitated the development of sophisticated molecular diagnostic tests for thyroid nodules, in the hopes of better risk stratifying nodules with indeterminate cytopathologic diagnosis. It is unclear whether the widespread, or reflexive, use of these tests will improve outcomes for patients with thyroid nodules. Thyroid nodules are a common and essentially normal finding. Even cytologically indeterminate thyroid nodules have a very low probability (approximately 1%) of representing clinically aggressive cancers and an even lower probability (approximately 0.1%) of representing lethal cancers. Therefore, most indeterminate thyroid nodules are low risk. Even if some will eventually require surgery, many can initially be kept under surveillance rather than requiring immediate surgery. Clinical and radiographic features can be helpful in risk stratifying these nodules. Molecular assays are marketed as tools to improve risk stratification for cy